Immune booster drugs meant to kill tumors found to improve Alzheimer's symptoms in mice

January 19, 2016 by Bob Yirka report
Credit: martha sexton/public domain

(MedicalXpress)—A team of researchers working at the Weizmann Institute of Science in Israel has found that a type of drug meant to help the immune system kill tumors also reduces Alzheimer's type symptoms in mouse models. In their paper published in the journal Nature Medicine, the team describes their study of drugs known as PD-1 immune checkpoint blockades, on mouse models, and the results they found.

As scientists close in on the cause of Alzheimer's disease and hopefully find a cure, more and more evidence points at problems with the immune system and inflammation as a factor. For the past several years, the prevailing view has been that an overactive immune system might be the root cause, but new studies have begun to suggest the opposite might be true—and that boosting the immune response in the brain might help reduce symptoms of the disease. In this new effort, the researchers looked at PD-1 immune checkpoint blockades because they do their work by disabling immunity checkpoints which is where the body sets up roadblocks to stop the immune system from attacking normal body parts. But tumors have been found to trick this same part of the immune system to prevent it from attacking them. Thus, the idea behind PD-1 blockers is to override the checkpoints and force the to attack the tumor anyway, causing it to shrink and disappear. In this new effort, the goal was to learn if such drugs might help stop or reverse the symptoms of Alzheimer's disease by boosting an in the brain.

To find out, the researchers genetically engineered test mice to develop Alzheimer's symptoms, both memory loss and the buildup of amyloid in the brain, and then gave each of them PD-1 blockers to see if it caused any improvement. They report that amyloid buildup in the brain of the mice was reduced by half and that most of them were once again able to make their way through a maze—a test of their memory abilities.

The research team notes that some PD-1 blockers are already on the market, Keytruda, for example has already been approved for use in treating tumors—thus, testing the drug on human patients in clinical trials should go rather quickly if further tests suggest it might actually work on people with Alzheimer's disease.

Explore further: Researchers target immune system in hunt for new Alzheimer's treatments

More information: Kuti Baruch et al. PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease, Nature Medicine (2016). DOI: 10.1038/nm.4022

Related Stories

Researchers target immune system in hunt for new Alzheimer's treatments

August 19, 2015
Researchers in Israel have manipulated the mouse immune system to target Alzheimer's disease. The research was published in the journal Nature Communications on 18 August 2015.

Study shows beneficial effects of blocking brain inflammation in experimental model of Alzheimer's

January 7, 2016
A University of Southampton-led study has found that blocking a receptor in the brain responsible for regulating immune cells could protect against the memory and behaviour changes seen in the progression of Alzheimer's disease.

Two amyloid-beta antibodies found to cause neuronal dysfunction in mice

November 10, 2015
(Medical Xpress)—A team of researchers working in Germany has found that giving two different types of amyloid-β antibodies to mice genetically engineered to have Alzheimer's type symptoms caused them to develop a type ...

Neurogeneticists harness immune cells to clear Alzheimer's-associated plaques

February 5, 2015
New research from scientists at the Keck School of Medicine of the University of Southern California (USC) shows that the body's immune system may be able to clear the brain of toxic plaque build-up that is the hallmark of ...

Chemical clears Alzheimer's protein and restores memory in mice

December 9, 2015
A research team in Korea has tested a chemical in mice genetically altered to develop features of Alzheimer's, showing it can remove a build-up of protein in the brain associated with the disease as well as rescuing memory ...

Study finds potential predictive biomarker for response to PD-L1 checkpoint blocker

November 26, 2014
A promising experimental immunotherapy drug works best in patients whose immune defenses initially rally to attack the cancer but then are stymied by a molecular brake that shuts down the response, according to a new study ...

Recommended for you

Delayed word processing could predict patients' potential to develop Alzheimer's disease

October 20, 2017
A delayed neurological response to processing the written word could be an indicator that a patient with mild memory problems is at an increased risk of developing Alzheimer's disease, research led by the University of Birmingham ...

PET scans for Alzheimer's could bring benefit to more patients

October 19, 2017
An imaging tool honed to spot rogue proteins in the brain could benefit some patients with suspected Alzheimer's, according to a new study.

One step closer toward a treatment for Alzheimer's disease?

October 18, 2017
Scientists at the Massachusetts General Hospital (MGH), in collaboration with colleagues at the University California, San Diego (UCSD), have characterized a new class of drugs as potential therapeutics for Alzheimer's disease ...

New mechanism detected in Alzheimer's disease

October 13, 2017
McGill University researchers have discovered a cellular mechanism that may contribute to the breakdown of communication between neurons in Alzheimer's disease.

Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer's disease

October 13, 2017
Microglia, immune cells that act as the central nervous system's damage sensors, have recently been implicated in Alzheimer's disease.

Green tea extract delivers molecular punch to disrupt formation of neurotoxic species

October 11, 2017
Green tea is widely considered to be beneficial for the brain. The antioxidant and detoxifying properties of green tea extracts help fight catastrophic diseases such as Alzheimer's. However, scientists have never fully understood ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.